Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2021-11-12
Product name:
PROVOCHOLINE INHALATION SOLUTION
Description:
SINGLE USE
DIN:
02276569
Product Monograph/Veterinary Labelling:
Date:
2022-10-28
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
METHAPHARM INC
81 Sinclair Blvd
Brantford
Ontario
Canada
N3S 7X6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Inhalation
Number of active ingredient(s):
5
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
36:89.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
V04CX OTHER DIAGNOSTIC AGENTS
Active ingredient group (AIG) number:See footnote5
0551578001
| Active ingredient(s) | Strength |
|---|---|
| METHACHOLINE CHLORIDE | 0.0625 MG / ML |
| METHACHOLINE CHLORIDE | 0.25 MG / ML |
| METHACHOLINE CHLORIDE | 1 MG / ML |
| METHACHOLINE CHLORIDE | 16 MG / ML |
| METHACHOLINE CHLORIDE | 4 MG / ML |